2025 BSR指南:传统合成改善病情抗风湿药物的处方和监测

2025-11-14 英国风湿病学会 Rheumatology (Oxford) 发表于上海

本文是对2017年发布的先前BSR指南的更新。修订羟氯喹剂量和监测方案,以及纳入voclosporin等新疗法。

中文标题:

2025 BSR指南:传统合成改善病情抗风湿药物的处方和监测

英文标题:

The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs

发布机构:

英国风湿病学会

发布日期:

2025-11-14

简要介绍:

改善病情抗风湿药物(DMARDs)在系统性自身免疫性风湿疾病(SARDs)的治疗中至关重要,有助于控制疾病活动并预防长期关节和组织损伤。传统合成改善病情抗风湿药物(csDMARDs)在带来获益的同时也有一定的风险。需要在开始治疗前进行适当筛查,治疗期间采取预防措施并定期监测,以减轻这些风险。本文是对2017年发布的先前BSR指南的更新。修订羟氯喹剂量和监测方案,以及纳入voclosporin等新疗法。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2025 BSR指南:传统合成改善病情抗风湿药物的处方和监测.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e06651c00a649808, title=2025 BSR指南:传统合成改善病情抗风湿药物的处方和监测, enTitle=The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs, guiderFrom=Rheumatology (Oxford), authorId=0, author=, summary=本文是对2017年发布的先前BSR指南的更新。修订羟氯喹剂量和监测方案,以及纳入voclosporin等新疗法。, cover=https://img.medsci.cn/Random/doctor-writing-D3K6QME.jpg, journalId=0, articlesId=null, associationId=442, associationName=英国风湿病学会, associationIntro=BSR promotes excellence in the treatment of people with arthritis and musculoskeletal conditions and supports those delivering it. We have over 25 years of expertise in promoting high quality standards of care, providing education, training and support to those working in rheumatology. We have more than 1,500 members including rheumatologists, scientists, trainees, allied health professionals and others from the UK and overseas., copyright=0, guiderPublishedTime=Fri Nov 14 00:00:00 CST 2025, originalUrl=, linkOutUrl=, content=<div class="guideDetailsCont flex-row-between-start" style="color: #333333;"> <div class="detailsContRight summary" style="color: #222222;" data-lines="12"><span class="text">改善病情抗风湿药物(DMARDs)在系统性自身免疫性风湿疾病(SARDs)的治疗中至关重要,有助于控制疾病活动并预防长期关节和组织损伤。传统合成改善病情抗风湿药物(csDMARDs)在带来获益的同时也有一定的风险。需要在开始治疗前进行适当筛查,治疗期间采取预防措施并定期监测,以减轻这些风险。本文是对2017年发布的先前BSR指南的更新。修订羟氯喹剂量和监测方案,以及纳入voclosporin等新疗法。</span></div> </div>, tagList=[TagDto(tagId=510077, tagName=改善病情抗风湿药物)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=510077, articleKeyword=改善病情抗风湿药物, articleKeywordNum=6, guiderKeywordId=510077, guiderKeyword=改善病情抗风湿药物, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=478, appHits=8, showAppHits=0, pcHits=103, showPcHits=468, likes=0, shares=0, comments=0, approvalStatus=1, publishedTime=Wed Nov 19 15:00:00 CST 2025, publishedTimeString=2025-11-14, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Nov 17 10:47:43 CST 2025, updatedBy=8538692, updatedName=梅斯话题小助手, updatedTime=Tue Nov 18 11:25:35 CST 2025, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2025 BSR指南:传统合成改善病情抗风湿药物的处方和监测.pdf)])
2025 BSR指南:传统合成改善病情抗风湿药物的处方和监测.pdf
下载请点击:
评论区 (0)
#插入话题